NINE MASTS CAPITAL Ltd bought a new position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 2,500 shares of the company’s stock, valued at approximately $206,000.
Several other institutional investors and hedge funds have also made changes to their positions in the company. BlackRock Inc. grew its position in shares of Nu Skin Enterprises by 11.5% during the second quarter. BlackRock Inc. now owns 6,143,407 shares of the company’s stock worth $480,352,000 after acquiring an additional 635,246 shares during the last quarter. William Blair Investment Management LLC grew its position in Nu Skin Enterprises by 6.8% in the 3rd quarter. William Blair Investment Management LLC now owns 1,263,139 shares of the company’s stock valued at $104,108,000 after buying an additional 80,117 shares during the last quarter. Bank of New York Mellon Corp grew its position in Nu Skin Enterprises by 0.4% in the 3rd quarter. Bank of New York Mellon Corp now owns 820,216 shares of the company’s stock valued at $67,601,000 after buying an additional 3,213 shares during the last quarter. Renaissance Technologies LLC grew its position in Nu Skin Enterprises by 51.1% in the 2nd quarter. Renaissance Technologies LLC now owns 814,000 shares of the company’s stock valued at $63,647,000 after buying an additional 275,200 shares during the last quarter. Finally, MERIAN GLOBAL INVESTORS UK Ltd grew its position in Nu Skin Enterprises by 4.2% in the 3rd quarter. MERIAN GLOBAL INVESTORS UK Ltd now owns 746,830 shares of the company’s stock valued at $61,553,000 after buying an additional 29,880 shares during the last quarter. Institutional investors and hedge funds own 74.66% of the company’s stock.
In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 2,500 shares of the firm’s stock in a transaction on Monday, December 3rd. The stock was sold at an average price of $67.53, for a total value of $168,825.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In the last three months, insiders sold 7,500 shares of company stock valued at $537,625. 5.20% of the stock is owned by corporate insiders.
Nu Skin Enterprises stock opened at $63.78 on Friday. Nu Skin Enterprises, Inc. has a one year low of $60.60 and a one year high of $88.68. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.93 and a quick ratio of 1.25. The firm has a market capitalization of $3.54 billion, a price-to-earnings ratio of 19.75, a price-to-earnings-growth ratio of 1.62 and a beta of 0.99.
Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Wednesday, November 7th. The company reported $0.94 EPS for the quarter, missing analysts’ consensus estimates of $0.96 by ($0.02). Nu Skin Enterprises had a net margin of 5.93% and a return on equity of 27.50%. The business had revenue of $675.31 million during the quarter, compared to analyst estimates of $664.99 million. During the same period last year, the business posted $0.76 EPS. Nu Skin Enterprises’s revenue was up 19.8% compared to the same quarter last year. On average, analysts predict that Nu Skin Enterprises, Inc. will post 3.51 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 12th. Shareholders of record on Friday, November 30th will be issued a $0.365 dividend. This represents a $1.46 dividend on an annualized basis and a yield of 2.29%. The ex-dividend date is Thursday, November 29th. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 45.20%.
A number of equities analysts recently weighed in on the stock. Zacks Investment Research lowered shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Tuesday, October 23rd. Tigress Financial reiterated a “buy” rating on shares of Nu Skin Enterprises in a research report on Wednesday, November 21st. Bank of America reiterated an “underperform” rating and issued a $65.00 price objective (down from $75.00) on shares of Nu Skin Enterprises in a research report on Thursday. Jefferies Financial Group reiterated a “buy” rating and issued a $92.00 price objective on shares of Nu Skin Enterprises in a research report on Thursday, November 8th. Finally, DA Davidson assumed coverage on shares of Nu Skin Enterprises in a research report on Tuesday, October 9th. They issued a “buy” rating and a $92.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the stock. Nu Skin Enterprises presently has a consensus rating of “Hold” and a consensus target price of $83.63.
WARNING: This piece was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at https://www.dispatchtribunal.com/2018/12/08/2500-shares-in-nu-skin-enterprises-inc-nus-purchased-by-nine-masts-capital-ltd.html.
Nu Skin Enterprises Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
See Also: What is Liquidity?
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.